Novel contributor to chemotherapy resistance: an interferon-dependent subtype of cancer-associated fibroblast

被引:0
|
作者
Chu Xiao
Chunxiang Li
Jie He
机构
[1] National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Department of Thoracic Surgery
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
    Kato, Manabu
    Placencio-Hickok, Veronica R.
    Madhav, Anisha
    Haldar, Subhash
    Tripathi, Manisha
    Billet, Sandrine
    Mishra, Rajeev
    Smith, Bethany
    Rohena-Rivera, Krizia
    Agarwal, Priyanka
    Duong, Frank
    Angara, Bryan
    Hickok, David
    Liu, Zhenqiu
    Bhowmick, Neil A.
    ONCOGENE, 2019, 38 (05) : 716 - 730
  • [22] Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
    Manabu Kato
    Veronica R. Placencio-Hickok
    Anisha Madhav
    Subhash Haldar
    Manisha Tripathi
    Sandrine Billet
    Rajeev Mishra
    Bethany Smith
    Krizia Rohena-Rivera
    Priyanka Agarwal
    Frank Duong
    Bryan Angara
    David Hickok
    Zhenqiu Liu
    Neil A. Bhowmick
    Oncogene, 2019, 38 : 716 - 730
  • [23] Targeting a myofibroblastic prostate cancer-associated fibroblast subtype through pharmacological inhibition of NADPH oxidase 4
    Brunner, Elena
    Neumann, Lucy
    Damisch, Elisabeth
    Puhr, Martin
    Schaefer, Georg
    Szyndralewiez, Cedric
    Klocker, Helmut
    Sampson, Natalie
    CANCER RESEARCH, 2022, 82 (12)
  • [24] Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance
    Galbo, Phillip M., Jr.
    Zang, Xingxing
    Zheng, Deyou
    CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2636 - 2647
  • [25] What is new in cancer-associated fibroblast biomarkers?
    Zehua Zhao
    Tianming Li
    Yuan Yuan
    Yanmei Zhu
    Cell Communication and Signaling, 21
  • [26] What is new in cancer-associated fibroblast biomarkers?
    Zhao, Zehua
    Li, Tianming
    Yuan, Yuan
    Zhu, Yanmei
    CELL COMMUNICATION AND SIGNALING, 2023, 21 (01)
  • [27] Epigenetic regulation of cancer-associated fibroblast heterogeneity
    Kehrberg, Rachel J.
    Bhyravbhatla, Namita
    Batra, Surinder K.
    Kumar, Sushil
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [28] Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer
    Sung Yeon Park
    Hye Min Kim
    Ja Seung Koo
    Breast Cancer Research and Treatment, 2015, 149 : 727 - 741
  • [29] Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer
    Park, Sung Yeon
    Kim, Hye Min
    Koo, Ja Seung
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 149 (03) : 727 - 741
  • [30] Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy
    Kadel, Dhruba
    Zhang, Yu
    Sun, Hao-Ran
    Zhao, Yue
    Dong, Qiong-Zhu
    Qin, Lun-xiu
    CELL BIOLOGY AND TOXICOLOGY, 2019, 35 (05) : 407 - 421